1. Non-small-cell lung cancer
2. Epidermal growth factor receptor mutations in lung cancer
3. Epidermal Growth Factor Receptor (EGFR) Signaling and Covalent EGFR Inhibition in Lung Cancer
4. Chinese society of clinical oncology non-small cell lung cancer c, anti-cancer drug safety management C. [Consensus on Application of Third-generation EGFR-TKI in EGFR Mutated NSCLC (2022 Version)]. Zhongguo Fei Ai Za Zhi. 2022;25:627–641. doi:10.3779/j.issn.1009-3419.2022.101.47
5. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up